Log in

Relevant bibliographies by topics / Rhinocoeta / Journal articles

To see the other types of publications on this topic, follow the link: Rhinocoeta.

Journal articles on the topic 'Rhinocoeta'

Author: Grafiati

Published: 4 June 2025

Last updated: 14 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 23 journal articles for your research on the topic 'Rhinocoeta.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Perissinotto, Renzo. "Description of a new species of Rhinocoeta Burmeister, 1842 (Scarabaeidae, Cetoniinae) from the South African Northern Cape." ZooKeys 848 (May 20, 2019): 41–56. https://doi.org/10.3897/zookeys.848.34207.

Full text

Abstract:

Rhinocoeta namaqua sp. nov. is recognised as a separate species from its closest relative, R. cornuta (Fabricius, 1781) after a review and close analysis of specimens recently collected in the semiarid region of the Northern Cape Province, South Africa. The new species can be readily separated from R. cornuta by the drastically reduced tubercle and associated depression on its anterior pronotal margin, particularly in the male. In addition, the general body shape of R. namaqua is more globose than that of R. cornuta, its average total length is larger, and its elytral costae are generally redu

APA, Harvard, Vancouver, ISO, and other styles

2

Perissinotto, Renzo. "Description of a new species of Rhinocoeta Burmeister, 1842 (Scarabaeidae, Cetoniinae) from the South African Northern Cape." ZooKeys 848 (May 20, 2019): 41–56. http://dx.doi.org/10.3897/zookeys.848.34207.

Full text

Abstract:

Rhinocoetanamaquasp. nov. is recognised as a separate species from its closest relative, R.cornuta (Fabricius, 1781) after a review and close analysis of specimens recently collected in the semiarid region of the Northern Cape Province, South Africa. The new species can be readily separated from R.cornuta by the drastically reduced tubercle and associated depression on its anterior pronotal margin, particularly in the male. In addition, the general body shape of R.namaqua is more globose than that of R.cornuta, its average total length is larger, and its elytral costae are generally reduced an

APA, Harvard, Vancouver, ISO, and other styles

3

Tos, Mirko, Frank Svendstrup, Helge Arndal, et al. "Efficacy of an Aqueous and a Powder Formulation of Nasal Budesonide Compared in Patients with Nasal Polyps." American Journal of Rhinology 12, no. 3 (1998): 183–90. http://dx.doi.org/10.2500/105065898781390217.

Full text

Abstract:

Nasal polyps are commonly treated surgically. Intranasal administration of topical corticosteroids has gained increased acceptance as a treatment alternative. The aim of our study was to compare the efficacy of treatment of two formulations of budesonide with placebo on nasal polyps. At four Danish clinics 138 patients suffering from moderate or severe nasal polyps were randomized to a twice daily treatment with Rhinocort® Aqua 128 μg, Rhinocort Turbuhaler® 140 μg or placebo (Astra Draco, Sweden) for 6 weeks. Polyp size (primary efficacy variable), nasal symptoms, sense of smell, and patients’

APA, Harvard, Vancouver, ISO, and other styles

4

&NA;. "FLUTICASONE (FLONASE); BUDESONIDE (RHINOCORT)." AJN, American Journal of Nursing 95, no. 3 (1995): 57–59. http://dx.doi.org/10.1097/00000446-199503000-00028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Taylor, KL. "Blepharocosta, a new genus of Australian Spondyliaspidinae (Hemiptera : Psylloidea)." Invertebrate Systematics 6, no. 1 (1992): 131. http://dx.doi.org/10.1071/it9920131.

Full text

Abstract:

A new genus, Blepharocosta, is erected for the species Rhinocola marmorata Froggatt, formerly placed in Australopsylla, and six new species, B. subsolana, B. cloezianae, B, phaeotrichae, B. baxtericola, B. marginaticola and B. minima. The host plants of all seven species, except one (Eucalyptus cloeziana), are species of Eucalyptus that belong to the subgenus Monocalyptus.

APA, Harvard, Vancouver, ISO, and other styles

6

Cockey, Carolyn Davis. "FDA Actions: Rhinocort Aqua Approved for Pregnancy Use." AWHONN Lifelines 8, no. 5 (2004): 410. http://dx.doi.org/10.1111/j.1552-6356.2004.tb00651.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Nakowitsch, Sabine, Christiane Koller, Jan-Marcus Seifert, et al. "Saponin Micelles Lead to High Mucosal Permeation and In Vivo Efficacy of Solubilized Budesonide." Pharmaceutics 12, no. 9 (2020): 847. http://dx.doi.org/10.3390/pharmaceutics12090847.

Full text

Abstract:

Due to fast nasal mucociliary clearance, only the dissolved drug content can effectively permeate the mucosa and be pharmaceutically active after intranasal application of suspensions. Therefore, the aim of this study was to increase the budesonide concentration in solution of a nasal spray formulation. Budesonide, a highly water-insoluble corticosteroid, was successfully solubilized using a micellar formulation comprising escin, propylene glycol and dexpanthenol in an aqueous buffered environment (“Budesolv”). A formulation based on this micellar system was well-tolerated in the nasal cavity

APA, Harvard, Vancouver, ISO, and other styles

8

Lashkari, M. "First record of Rhinocola aceris (L. 1758) (Hemiptera: Aphalaridae ) in Iran." Afghanistan Research Journal - Natural Science 43, no. 2 (2023): 191–94. http://dx.doi.org/10.61186/jesi.43.2.9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Zieglmayer, isabel, René Schmutz, Patrick Lemell, et al. "A novel formulation of budesonide nasal spray (Budesolv 10) potentiates clinical performance in grass pollen allergic patients." Journal of Immunology 204, no. 1_Supplement (2020): 65.28. http://dx.doi.org/10.4049/jimmunol.204.supp.65.28.

Full text

Abstract:

Abstract Objective Purpose of this DBPC study was to evaluate onset of action and non-inferiority of a novel low dose aqueous solution of Budesonide (“Budesolv 10μg”) to Rhinocort® aqua 64μg (RA) in adult grass pollen allergic patients. Methods Budesonide, a poorly water-soluble corticosteroid, currently marketed as suspension, was reformulated to enhance solubility and local concentration on the target mucosa. Subjects received Budesolv, the market comparator RA and placebo once daily for 8 days. Allergic symptoms were induced by 6h grass pollen challenges in the Vienna Challenge Chamber at d

APA, Harvard, Vancouver, ISO, and other styles

10

Day, James, Michael Alexander, Michel Drouin, et al. "Budesonide Aqueous Nasal Spray and Pressurized Metered Dose Inhaler in the Treatment of Adult Patients with Seasonal Allergic Rhinitis." American Journal of Rhinology 11, no. 1 (1997): 77–84. http://dx.doi.org/10.2500/105065897781446847.

Full text

Abstract:

Budesonide, a topical corticosteroid used in the treatment of seasonal allergic rhinitis, can be administered to the nose as an aerosol via a pressurized metered dose inhaler (pMDI) or as a metered nasal pump spray. Studies have shown that about 64% (256 μg) of a nominal dose of 400 μg budesonide pMDI preparation is delivered to the patient compared with 100% of the nominal dose of the pump spray. The present study was undertaken to assess the efficacy and safety of budesonide delivered via a nasal pMDI twice daily (Rhinocort® pMDI, at 400 μg/day) with an aqueous suspension of budesonide deliv

APA, Harvard, Vancouver, ISO, and other styles

11

Devalia, J. L., D. Prime, and D. H. Richards. "Effect of Variable Inspiratory Flow Rate on the Performance of the Budesonide Rhinocort Turbuhaler???" Clinical Drug Investigation 21, no. 3 (2001): 195–201. http://dx.doi.org/10.2165/00044011-200121030-00005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

FOKKENS, W. "1145 Efficacy of budesonide aqueous nasal spray (rhinocortS aqua) in children with perennial allergic rhinitis." Journal of Allergy and Clinical Immunology 105, no. 1 (2000): S392—S393. http://dx.doi.org/10.1016/s0091-6749(00)91571-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Creticos, Peter, Philip Fireman, Guy Settipane, et al. "Intranasal Budesonide Aqueous Pump Spray (Rhinocort® Aqua) for the Treatment of Seasonal Allergic Rhinitis." Allergy and Asthma Proceedings 19, no. 5 (1998): 285–94. http://dx.doi.org/10.2500/108854198778557692.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

JOHANSEN, LARS VENDELBO, PETER ILLUM, SØREN KRISTENSEN, LEO WINTHER, SVEND VANG PETERSEN, and BJÖRN SYNNERSTAD. "The effect of budesonide (Rhinocort�) in the treatment of small and medium-sized nasal polyps." Clinical Otolaryngology 18, no. 6 (1993): 524–27. http://dx.doi.org/10.1111/j.1365-2273.1993.tb00628.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

O'Dowd, Liza, Lars Thorsson, and Staffan Edsbacker. "Systemic availability of Rhinocort Aqua (budesonide) nasal spray: Importance of formulation and definition of delivered dose." Journal of Allergy and Clinical Immunology 109, no. 6 (2002): 1037. http://dx.doi.org/10.1067/mai.2002.125260.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Day, James H., Maureen P. Briscoe, Elizabeth Rafeiro, Anne K. Ellis, Eva Pettersson, and Anders Åkerlund. "Onset of action of intranasal budesonide (Rhinocort Aqua) in seasonal allergic rhinitis studied in a controlled exposure model." Journal of Allergy and Clinical Immunology 105, no. 3 (2000): 489–94. http://dx.doi.org/10.1067/mai.2000.104550.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

&NA;. "The US FDA has approved an upgrade to the pregnancy rating for AstraZeneca's Rhinocort Aqua [budesonide] to Category B,." Reactions Weekly &NA;, no. 1018 (2004): 2. http://dx.doi.org/10.2165/00128415-200410180-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Pozzoli, Michele, Philippe Rogueda, Bing Zhu, et al. "Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulation." Drug Development and Industrial Pharmacy 42, no. 10 (2016): 1660–68. http://dx.doi.org/10.3109/03639045.2016.1160110.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Naclerio, Robert M., Fuad M. Baroody, Nalini Bidani, Tineo Marcy De, and Bill C. Penney. "A Comparison of Nasal Clearance after Treatment of Perennial Allergic Rhinitis with Budesonide and Mometasone." Otolaryngology–Head and Neck Surgery 128, no. 2 (2003): 220–27. http://dx.doi.org/10.1067/mhn.2003.70.

Full text

Abstract:

OBJECTIVE: Evidence in vitro suggests that benzalkonium chloride, a preservative in many intranasal preparations, interferes with ciliary function and thus could potentially interfere with mucociliary transport, the mechanism for clearing secretions from the nasal cavity. STUDY DESIGN: We performed a parallel randomized study with 10 subjects in each arm comparing Rhinocort AQUA (an intranasal steroid (budesonide) spray without benzalkonium chloride) and Nasonex (an intranasal steroid (mometasone furoate) spray with benzalkonium chloride). Before and after 2 weeks of treatment, subjects comple

APA, Harvard, Vancouver, ISO, and other styles

20

Lund, V., S. Black, Zs László, C. Schrewelius, and A. Åkerlund. "Budesonide aqueous nasal spray (BANS: Rhinocort® aqua™) is effective as monotherapy in stable patients with chronic rhinosinusitis (CRS)." Journal of Allergy and Clinical Immunology 109, no. 1 (2002): S290. http://dx.doi.org/10.1016/s0091-6749(02)82021-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Basran, G. S., D. V. McGivern, S. Hanley, and D. Davies. "The Efficacy of Budesonide and Beclomethasone Dipropionate, Delivered via a Pressurized Metered Dose Inhaler, in the Treatment of Perennial Rhinitis: A Randomized, Double-Blind, Crossover Study." American Journal of Rhinology 9, no. 5 (1995): 285–90. http://dx.doi.org/10.2500/105065895781808838.

Full text

Abstract:

A total of 28 adult patients (19 women, nine men; mean age 28.5 years, range 15–63 years) with a diagnosis of perennial allergic and nonallergic rhinitis (mean duration of symptoms 4.0 years, range 1–20 years) were recruited into this randomized, double-blind, crossover study. Eighteen patients (64%) were atopic for common allergens. The efficacy of budesonide nasal aerosol (Rhinocort®) and beclomethasone dipropionate (BDP; Beconase®) was compared using nominal doses of 200 μg (b.i.d.) for each drug administered every morning and evening. Following a 2-week run-in period, patients were randoml

APA, Harvard, Vancouver, ISO, and other styles

22

MURPHY, K. "Recommended once-daily dose of budesonide aqueous nasal spray (Rhinocort AquaS) does not suppress growth velocity in pediatric patients with perennial allergic rhinitis*1." Journal of Allergy and Clinical Immunology 113, no. 2 (2004): S175. http://dx.doi.org/10.1016/j.jaci.2004.01.065.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Zieglmayer, Petra, Patrick Lemell, Nicole Unger-Manhart, Andreas Goessl, René Zieglmayer, and Eva Prieschl-Grassauer. "Therapeutic equivalence and early onset of action of a novel water-soluble budesonide nasal spray (Budesolv 10) compared to Rhinocort® aqua 64 in patients suffering from grass pollen induced allergic rhinitis with or without asthma." World Allergy Organization Journal 13, no. 8 (2020): 100261. http://dx.doi.org/10.1016/j.waojou.2020.100261.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!